159 related articles for article (PubMed ID: 8242901)
1. Systemic and mucosal IgA responses to systemic antigen challenge in IgA nephropathy.
Layward L; Finnemore AM; Allen AC; Harper SJ; Feehally J
Clin Immunol Immunopathol; 1993 Dec; 69(3):306-13. PubMed ID: 8242901
[TBL] [Abstract][Full Text] [Related]
2. Response to mucosal antigen challenge in IgA nephropathy.
Layward L; Allen AC; Hattersley JM; Harper SJ; Feehally J
Exp Nephrol; 1995; 3(5):300-7. PubMed ID: 7583052
[TBL] [Abstract][Full Text] [Related]
3. Decreased IgA1 response after primary oral immunization with live typhoid vaccine in primary IgA nephropathy.
Roodnat JI; de Fijter JW; van Kooten C; Daha MR; van Es LA
Nephrol Dial Transplant; 1999 Feb; 14(2):353-9. PubMed ID: 10069188
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of IgG subclass antibody response to tetanus toxoid associated with high serum IgA levels in IgA nephropathy.
Layward L; Allen AC; Harper SJ; Hattersley JM; Feehally J
Clin Nephrol; 1993 Sep; 40(3):131-6. PubMed ID: 8403566
[TBL] [Abstract][Full Text] [Related]
5. Specific IgA subclass responses in serum and saliva: a 12-month follow-up study after parenteral booster immunization with tetanus toxoid.
Engström PE; Gustafson R; Granberg M; Engström GN
Acta Odontol Scand; 2002 Aug; 60(4):198-202. PubMed ID: 12222642
[TBL] [Abstract][Full Text] [Related]
6. Increased and prolonged production of specific polymeric IgA after systemic immunization with tetanus toxoid in IgA nephropathy.
Layward L; Allen AC; Harper SJ; Hattersley JM; Feehally J
Clin Exp Immunol; 1992 Jun; 88(3):394-8. PubMed ID: 1606721
[TBL] [Abstract][Full Text] [Related]
7. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.
Smith AC; Molyneux K; Feehally J; Barratt J
J Am Soc Nephrol; 2006 Dec; 17(12):3520-8. PubMed ID: 17093066
[TBL] [Abstract][Full Text] [Related]
8. Elevation of IgA in IgA nephropathy is localized in the serum and not saliva and is restricted to the IgA1 subclass.
Layward L; Allen AC; Hattersley JM; Harper SJ; Feehally J
Nephrol Dial Transplant; 1993; 8(1):25-8. PubMed ID: 8381930
[TBL] [Abstract][Full Text] [Related]
9. Secretory immunoglobulin A (IgA) responses in IgA nephropathy patients after mucosal immunization, as part of a polymeric IgA response.
Eijgenraam JW; Oortwijn BD; Kamerling SW; de Fijter JW; van den Wall Bake AW; Daha MR; van Kooten C
Clin Exp Immunol; 2008 May; 152(2):227-32. PubMed ID: 18336594
[TBL] [Abstract][Full Text] [Related]
10. Decreased cytokine-induced IgA subclass production by CD40-ligated circulating B cells in primary IgA nephropathy.
de Fijter JW; van Nisselrooij NI; Schroeijers WE; Daha MR; van Es LA; van Kooten C
Nephrol Dial Transplant; 1998 Feb; 13(2):285-92. PubMed ID: 9509436
[TBL] [Abstract][Full Text] [Related]
11. Systemic immune response after mucosal immunization in patients with IgA nephropathy.
Waldo FB
J Clin Immunol; 1992 Jan; 12(1):21-6. PubMed ID: 1551939
[TBL] [Abstract][Full Text] [Related]
12. T and B cell responses following immunization with tetanus toxoid in IgA nephropathy.
Fortune F; Courteau M; Williams DG; Lehner T
Clin Exp Immunol; 1992 Apr; 88(1):62-7. PubMed ID: 1532927
[TBL] [Abstract][Full Text] [Related]
13. Low antibody affinity restricted to the IgA isotype in IgA nephropathy.
Layward L; Allen AC; Hattersley JM; Harper SJ; Feehally J
Clin Exp Immunol; 1994 Jan; 95(1):35-41. PubMed ID: 8287607
[TBL] [Abstract][Full Text] [Related]
14. Increased IgA and decreased IgG production by Epstein-Barr virus transformed B cells in culture in IgA nephropathy.
Layward L; Allen AC; Harper SJ; Feehally J
Exp Nephrol; 1994; 2(1):24-9. PubMed ID: 8081994
[TBL] [Abstract][Full Text] [Related]
15. Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy.
Zachova K; Kosztyu P; Zadrazil J; Matousovic K; Vondrak K; Hubacek P; Julian BA; Moldoveanu Z; Novak Z; Kostovcikova K; Raska M; Mestecky J
Front Immunol; 2020; 11():267. PubMed ID: 32184780
[TBL] [Abstract][Full Text] [Related]
16. Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy.
de Fijter JW; Eijgenraam JW; Braam CA; Holmgren J; Daha MR; van Es LA; van den Wall Bake AW
Kidney Int; 1996 Sep; 50(3):952-61. PubMed ID: 8872971
[TBL] [Abstract][Full Text] [Related]
17. Patients with IgA nephropathy respond strongly through production of IgA with low avidity against Staphylococcus aureus.
Shimizu Y; Seki M; Kaneko S; Hagiwara M; Yoh K; Yamagata K; Koyama A
Contrib Nephrol; 2007; 157():139-43. PubMed ID: 17495452
[TBL] [Abstract][Full Text] [Related]
18. IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1.
Suzuki H; Moldoveanu Z; Hall S; Brown R; Julian BA; Wyatt RJ; Tomana M; Tomino Y; Novak J; Mestecky J
Contrib Nephrol; 2007; 157():129-33. PubMed ID: 17495450
[TBL] [Abstract][Full Text] [Related]
19. Experimental IgA-IgG nephropathy induced by a viral respiratory pathogen. Dependence on antigen form and immune status.
Jessen RH; Emancipator SN; Jacobs GH; Nedrud JG
Lab Invest; 1992 Sep; 67(3):379-86. PubMed ID: 1328763
[TBL] [Abstract][Full Text] [Related]
20. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
